The results showed that the MFAP2 m1A methylation level in CRC patients at N1‐2, M1, AJCC3 + 4 stages was higher than those patients at N0, M0, AJCC1 + 2 stages (Figure S4). Here, MFAP2 is linked to colorectal carcinoma.